A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome

Completed · Phase 3 · Has a placebo group

Conditions studied: Lennox Gastaut Syndrome

In brief

This is a two-part, multicenter, double-blind, parallel-group, placebo controlled study to evaluate the effect of ZX008 when used as adjunctive therapy for the treatment of uncontrolled seizures in children and adults with Lennox-Gastaut syndrome (LGS).

Key facts

Study ID
NCT03355209
Run by
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
People needed
296
Starts
2017-11-27
Expected to finish
2024-05-23
Last updated by the study team
2025-07-03

Who can join

Age: 2 and older, up to 35. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.